STAT@JPM: Health Care at a Crossroads

Never has so much been at stake when it comes to investments in health care. All kinds of uncertainty — political, social, and scientific — stand between new preventatives, treatments, and cures and the patients who need them. But never has investment been more important either. Join us for a look at what is at stake, what is ahead, and ideas for developing new medicines in 2026.

Featured Speakers

• Yvonne Greenstreet, M.D., MBA, OBE, chief executive officer, Alnylam Pharmaceuticals
• Agustin Mohedas, Ph.D., portfolio manager, research analyst, Janus Henderson Investments
• Roderick Wong, M.D., managing partner, chief investment officer, RTW
• Teresa Graham, chief executive officer, Roche Pharmaceuticals (sponsor speaker)